116 related articles for article (PubMed ID: 15509685)
1. Karyometry detects subvisual differences in chromatin organisation state between non-recurrent and recurrent papillary urothelial neoplasms of low malignant potential.
Scarpelli M; Montironi R; Tarquini LM; Hamilton PW; López Beltran A; Ranger-Moore J; Bartels PH
J Clin Pathol; 2004 Nov; 57(11):1201-7. PubMed ID: 15509685
[TBL] [Abstract][Full Text] [Related]
2. Chromatin phenotype karyometry can predict recurrence in papillary urothelial neoplasms of low malignant potential.
Montironi R; Scarpelli M; Lopez-Beltran A; Mazzucchelli R; Alberts D; Ranger-Moore J; Bartels HG; Hamilton PW; Einspahr J; Bartels PH
Cell Oncol; 2007; 29(1):47-58. PubMed ID: 17429141
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical evaluation of global DNA methylation and histone acetylation in papillary urothelial neoplasm of low malignant potential.
Barbisan F; Mazzucchelli R; Santinelli A; Stramazzotti D; Scarpelli M; Lopez-Beltran A; Cheng L; Montironi R
Int J Immunopathol Pharmacol; 2008; 21(3):615-23. PubMed ID: 18831929
[TBL] [Abstract][Full Text] [Related]
4. Subvisual changes in chromatin organization state are detected by karyometry in the histologically normal urothelium in patients with synchronous papillary carcinoma.
Montironi R; Scarpelli M; Mazzucchelli R; Hamilton PW; Thompson D; Ranger-Moore J; Bostwick DG; Bartels PH
Hum Pathol; 2003 Sep; 34(9):893-901. PubMed ID: 14562285
[TBL] [Abstract][Full Text] [Related]
5. Global acetylation and methylation changes predict papillary urothelial neoplasia of low malignant potential recurrence: a quantitative analysis.
Mazzucchelli R; Scarpelli M; Lopez-Beltran A; Cheng L; Bartels H; Bartels PH; Alberts DS; Montironi R
Int J Immunopathol Pharmacol; 2011; 24(2):489-97. PubMed ID: 21658323
[TBL] [Abstract][Full Text] [Related]
6. Strong immunohistochemical expression of fibroblast growth factor receptor 3, superficial staining pattern of cytokeratin 20, and low proliferative activity define those papillary urothelial neoplasms of low malignant potential that do not recur.
Barbisan F; Santinelli A; Mazzucchelli R; Lopez-Beltran A; Cheng L; Scarpelli M; van der Kwast T; Montironi R
Cancer; 2008 Feb; 112(3):636-44. PubMed ID: 18072261
[TBL] [Abstract][Full Text] [Related]
7. Recurrent papillary urothelial neoplasm of low malignant potential. Subtle architectural disorder detected by quantitative analysis in DAXX-immunostained tissue sections.
Castellini P; Montironi MA; Zizzi A; Scarpelli M; Mazzucchelli R; Lopez-Beltran A; Cheng L; Paone N; Montironi R
Hum Pathol; 2014 Apr; 45(4):745-52. PubMed ID: 24565208
[TBL] [Abstract][Full Text] [Related]
8. Karyometry detects subvisual differences in chromatin organization state between cribriform and flat high-grade prostatic intraepithelial neoplasia.
Montironi R; Thompson D; Scarpelli M; Mazzucchelli R; Peketi P; Hamilton PW; Bostwick DG; Bartels PH
Mod Pathol; 2004 Aug; 17(8):928-37. PubMed ID: 15105811
[TBL] [Abstract][Full Text] [Related]
9. Karyometry in rectal mucosa of patients with previous colorectal adenomas.
Ranger-Moore J; Frank D; Lance P; Alberts D; Yozwiak M; Bartels HG; Einspahr J; Bartels PH
Anal Quant Cytol Histol; 2005 Jun; 27(3):134-42. PubMed ID: 16121634
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcome of primary Papillary Urothelial Neoplasm of Low Malignant Potential (PUNLMP) including PUNLMP with inverted growth.
Maxwell JP; Wang C; Wiebe N; Yilmaz A; Trpkov K
Diagn Pathol; 2015 Mar; 10():3. PubMed ID: 25886613
[TBL] [Abstract][Full Text] [Related]
11. Urothelial neoplasms in patients 20 years or younger: a clinicopathological analysis using the world health organization 2004 bladder consensus classification.
Fine SW; Humphrey PA; Dehner LP; Amin MB; Epstein JI
J Urol; 2005 Nov; 174(5):1976-80. PubMed ID: 16217372
[TBL] [Abstract][Full Text] [Related]
12. Short telomeres and chromosome instability prior to histologic malignant progression and cytogenetic aneuploidy in papillary urothelial neoplasms.
Izumiyama-Shimomura N; Nakamura K; Aida J; Ishikawa N; Kuroiwa M; Hiraishi N; Fujiwara M; Ishikawa Y; Inoshita N; Yonese J; Matsuura M; Poon SS; Arai T; Takubo K
Urol Oncol; 2014 Feb; 32(2):135-45. PubMed ID: 23510865
[TBL] [Abstract][Full Text] [Related]
13. An image analysis study on nuclear morphology in metastasized and non-metastasized squamous cell carcinomas of the tongue.
Hannen EJ; van der Laak JA; Manni JJ; Pahlplatz MM; Freihofer HP; Slootweg PJ; Koole R; de Wilde PC
J Pathol; 1998 Jun; 185(2):175-83. PubMed ID: 9713344
[TBL] [Abstract][Full Text] [Related]
14. Potential of radial basis function neural networks in discriminating benign from malignant lesions of the lower urinary tract.
Karakitsos P; Pouliakis A; Kordalis G; Georgoulakis J; Kittas C; Kyroudes A
Anal Quant Cytol Histol; 2005 Feb; 27(1):35-42. PubMed ID: 15794450
[TBL] [Abstract][Full Text] [Related]
15. High-grade papillary urothelial carcinoma of the urinary tract: a clinicopathologic analysis of a post-World Health Organization/International Society of Urological Pathology classification cohort from a single academic center.
Chaux A; Karram S; Miller JS; Fajardo DA; Lee TK; Miyamoto H; Netto GJ
Hum Pathol; 2012 Jan; 43(1):115-20. PubMed ID: 21820145
[TBL] [Abstract][Full Text] [Related]
16. Significance of denuded urothelium in papillary urothelial lesions.
Owens CL; Epstein JI
Am J Surg Pathol; 2007 Feb; 31(2):298-303. PubMed ID: 17255776
[TBL] [Abstract][Full Text] [Related]
17. Genomic aberrations are rare in urothelial neoplasms of patients 19 years or younger.
Wild PJ; Giedl J; Stoehr R; Junker K; Boehm S; van Oers JM; Zwarthoff EC; Blaszyk H; Fine SW; Humphrey PA; Dehner LP; Amin MB; Epstein JI; Hartmann A
J Pathol; 2007 Jan; 211(1):18-25. PubMed ID: 17072825
[TBL] [Abstract][Full Text] [Related]
18. Polypoid/papillary cystitis: a series of 41 cases misdiagnosed as papillary urothelial neoplasia.
Lane Z; Epstein JI
Am J Surg Pathol; 2008 May; 32(5):758-64. PubMed ID: 18379418
[TBL] [Abstract][Full Text] [Related]
19. Papillary urothelial neoplasms of low malignant potential. Clinical and biologic implications.
Cheng L; Neumann RM; Bostwick DG
Cancer; 1999 Nov; 86(10):2102-8. PubMed ID: 10570438
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of the 2004 WHO/ISUP classification for prediction of recurrence, progression, and cancer-specific mortality of non-muscle-invasive urothelial tumors of the urinary bladder: a clinicopathologic study of 1,515 cases.
Pan CC; Chang YH; Chen KK; Yu HJ; Sun CH; Ho DM
Am J Clin Pathol; 2010 May; 133(5):788-95. PubMed ID: 20395527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
